Medicaid programs engage in a large amount of unnecessary and wasteful drug spending by reimbursing pharmacies for relatively costly brand products when identical generic products are available.

Aid agencies, advocates, and national governments have a responsibility to ensurethatbillions of dollars inpharmaceutical procurementare spent on safe, effective, life-saving drugs.